Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 3/20 | 0.35 |
| ▸ | CYP11B1 | P15538 | 5/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.32 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.32 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 2/20 | 0.30 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18540375 | 0.79 | CYP11B1 (0.36) | KDM1ACYP11B1CYP11B2CYP3A4HSD17B1 | |
| SCHEMBL18540383 | 0.78 | HSD17B1 (0.39) | KDM1ACYP11B1CYP11B2CYP3A4HSD17B1 | |
| SCHEMBL18540374 | 0.74 | KDM1A (0.35) | KDM1ADHODHCYP11B1CYP11B2CYP3A4 | |
| SCHEMBL13798949 | 0.74 | LDHA (0.48) | CYP11B1CYP11B2CYP3A4LDHAIDO1 | |
| SCHEMBL13798953 | 0.74 | LDHA (0.48) | CYP11B1CYP11B2CYP3A4LDHAIDO1 | |
| SCHEMBL17952949 | 0.73 | HSD17B1 (0.53) | DHODHCYP11B1CYP11B2HSD17B1HSD17B2 | |
| SCHEMBL24134487 | 0.73 | HSD17B1 (0.38) | KDM1ACYP11B1CYP11B2CYP3A4HSD17B1 | |
| SCHEMBL18540379 | 0.72 | KDM1A (0.34) | KDM1ADHODHCYP11B1CYP11B2CYP3A4 | |
| SCHEMBL24559523 | 0.72 | L3MBTL1 (0.42) | KDM1ACYP3A4 | |
| SCHEMBL12000719 | 0.72 | APP (0.35) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170054095-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD., (KR) | 2017-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170054095-A1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, LEF1, POU2F1 | KDM1A 326/4885DHODH 1537/4885CYP11B1 766/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.